Novo Nordisk Confirms Omnicom as U.S. Media Assignment After Review
Novo Nordisk confirmed that Omnicom has won its U.S. media assignment after a review, ending speculation around the outcome. The company spends more than $600M annually on media and previously used WPP’s Wavemaker in the U.S. The award comes as Novo Nordisk pursues legal action against Eli Lilly over alleged false GLP-1 advertising.